首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称:
商品名称:
药品NDC:
上市日期:
-
格式:2020-5-3
注册申请号:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC数据库排除药物数据库文件
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Estazolam
DRUG FOR FURTHER PROCESSING
0591-0744
Actavis Pharma, Inc.
20141119
ESTAZOLAM
DRUG FOR FURTHER PROCESSING
1
0591-0744_efa63d95-b4b9-46ae-8f1b-5d0c75e1fc69
Estazolam
DRUG FOR FURTHER PROCESSING
0591-0745
Actavis Pharma, Inc.
20141119
ESTAZOLAM
DRUG FOR FURTHER PROCESSING
2
0591-0745_efa63d95-b4b9-46ae-8f1b-5d0c75e1fc69
Dicyclomine Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-0794
Actavis Pharma, Inc.
20240624
DICYCLOMINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10
0591-0794_3ceb82f3-b6fb-43b0-82ff-66ca844ae1c0
Dicyclomine Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-0795
Actavis Pharma, Inc.
20240104
DICYCLOMINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
20
0591-0795_3ceb82f3-b6fb-43b0-82ff-66ca844ae1c0
Lisinopril and hydrochlorothiazide
DRUG FOR FURTHER PROCESSING
0591-0860
Actavis Pharma, Inc.
20030301
HYDROCHLOROTHIAZIDE; LISINOPRIL
DRUG FOR FURTHER PROCESSING
12.5; 10
0591-0860_6ec7d3cd-452d-42e0-ac10-8730bb3f0ba6
Lisinopril and hydrochlorothiazide
DRUG FOR FURTHER PROCESSING
0591-0861
Actavis Pharma, Inc.
20030301
HYDROCHLOROTHIAZIDE; LISINOPRIL
DRUG FOR FURTHER PROCESSING
12.5; 20
0591-0861_6ec7d3cd-452d-42e0-ac10-8730bb3f0ba6
Lisinopril and hydrochlorothiazide
DRUG FOR FURTHER PROCESSING
0591-0862
Actavis Pharma, Inc.
20030301
HYDROCHLOROTHIAZIDE; LISINOPRIL
DRUG FOR FURTHER PROCESSING
25; 20
0591-0862_6ec7d3cd-452d-42e0-ac10-8730bb3f0ba6
Lisinopril
DRUG FOR FURTHER PROCESSING
0591-0885
Actavis Pharma, Inc.
20020701
LISINOPRIL
DRUG FOR FURTHER PROCESSING
30
0591-0885_3fdfd3c3-b1bd-46a3-a105-218aa6ebb0cd
Ramelteon
DRUG FOR FURTHER PROCESSING
0591-2191
Actavis Pharma, Inc.
20190722
RAMELTEON
DRUG FOR FURTHER PROCESSING
8
0591-2191_5f00542f-cea9-4b0b-8c85-870aca45cfdc
Propafenone Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2285
Actavis Pharma, Inc.
20150922
PROPAFENONE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
225
0591-2285_706f24c4-1514-4434-88a9-dc8e80327148
Propafenone Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2286
Actavis Pharma, Inc.
20150922
PROPAFENONE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
325
0591-2286_706f24c4-1514-4434-88a9-dc8e80327148
Propafenone Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2287
Actavis Pharma, Inc.
20150922
PROPAFENONE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
425
0591-2287_706f24c4-1514-4434-88a9-dc8e80327148
Alvimopan
DRUG FOR FURTHER PROCESSING
0591-2312
Actavis Pharma, Inc.
20201013
ALVIMOPAN
DRUG FOR FURTHER PROCESSING
12
0591-2312_60f84bf9-5853-4ab1-842f-118f1e146f8a
Ambrisentan
DRUG FOR FURTHER PROCESSING
0591-2405
Actavis Pharma, Inc.
20190328
AMBRISENTAN
DRUG FOR FURTHER PROCESSING
5
0591-2405_acd86326-b7d1-4a7c-90ec-1c13411b0a56
Ambrisentan
DRUG FOR FURTHER PROCESSING
0591-2406
Actavis Pharma, Inc.
20190328
AMBRISENTAN
DRUG FOR FURTHER PROCESSING
10
0591-2406_acd86326-b7d1-4a7c-90ec-1c13411b0a56
Tetracycline Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2474
Actavis Pharma, Inc.
20110815
TETRACYCLINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
250
0591-2474_bbf3aec2-da2d-4235-8206-cd83d0faa1e2
Tetracycline Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-2475
Actavis Pharma, Inc.
20110815
TETRACYCLINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
500
0591-2475_bbf3aec2-da2d-4235-8206-cd83d0faa1e2
bosentan
DRUG FOR FURTHER PROCESSING
0591-2511
Actavis Pharma, Inc.
20190603
BOSENTAN
DRUG FOR FURTHER PROCESSING
62.5
0591-2511_551135a3-ddc1-40c2-9281-2383a0a23d4a
bosentan
DRUG FOR FURTHER PROCESSING
0591-2512
Actavis Pharma, Inc.
20190603
BOSENTAN
DRUG FOR FURTHER PROCESSING
125
0591-2512_551135a3-ddc1-40c2-9281-2383a0a23d4a
Chlorzoxazone
DRUG FOR FURTHER PROCESSING
0591-2520
Actavis Pharma, Inc.
20110822
CHLORZOXAZONE
DRUG FOR FURTHER PROCESSING
500
0591-2520_b79e689c-952a-48ee-9b76-f386a566936a
首页
(current)
27
(current)
28
(current)
29
(current)
30
(current)
31
(current)
32
(current)
33
(current)
34
(current)
35
(current)
36
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
医药研究数据
|
医药资料
|
SDA药品评审中心
|
中医网
|
中药处方系统
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: